InactivatedVaccineSafetyTest_QualityChecker
Inactivated Vaccine Safety Test
Huvac human vaccines vaccination adjuvants mRNA vaccines sterility endotoxins cold chain
Open selectionUtility description: Inactivated Vaccine Safety Test
Inactivated Vaccine Safety Test Quality Checker — Control of Inactivated Vaccine Safety (Inactivation Test)
ℹ️ Utility assesses the completeness of pathogen inactivation in inactivated vaccines (IPV, Rabies, Influenza, Encephalitis) according to Ph. Eur. 2.6.16, 2.6.17 and WHO requirements:
• Absence of live virus: None of the subcultures should show signs of virus replication (CPE).
• Observation Duration: Usually 14–21 days to ensure detection of slow-growing viruses.
• System Validity: Cell control must be viable, and virus control (sensitivity) must show growth.
• Residual Inactivator: Control of formalin or beta-propiolactone (BPL) levels.
⚠️ CRITICAL:
• Detection of even one positive subculture means INCOMPLETE INACTIVATION. This is a critical batch failure.
• Invalid virus control (no growth) renders the test invalid, as we cannot be sure of system sensitivity.
Usage:
InactivatedVaccineSafetyTestQualityChecker.exe → demo mode (console output)
InactivatedVaccineSafetyTestQualityChecker.exe input.csv output.json → evaluate your data
Input format:
BatchNumber,ProductName,TotalSubcultures,PositiveSubcultures,IncubationDays,CellControlSurvival_Percent,VirusControlTiter_Log10,InactivatingAgent,ResidualInactivator_ppm
Example:
INV-SAFE-001,IPV,3,0,21,95.0,6.5,Formalin,15.0
— WHY IS THIS NEEDED?
For inactivated vaccines, safety is the absolute priority. If the inactivation process (chemical or physical) was compromised, the vaccine may cause the disease it is intended to prevent.
The Safety Test (Inactivation Test) is mandatory for the release of every batch.
⚠️ CRITICAL:
• Subcultivation: Process of repeated seeding of material onto fresh cells to amplify signal if virus is present in trace amounts.
• Sensitivity: Method must be able to detect 1 infectious dose.
• Residual Inactivator: Its presence in small doses is sometimes required to guarantee that any accidental survivors are inactivated during storage, but its level is strictly toxicologically limited.
• Specificity: Used cell lines must be susceptible to the given virus.
Key features:
• Strict control of absence of live pathogen (Zero Tolerance)
• Test system validity check (controls)
• Monitoring of chemical inactivation agent residues
• Generation of reports for regulatory authorities and LIMS LabWare
• Compliance with GMP and Pharmacopoeia requirements
Critical parameters:
• Positive Subcultures: 0 (Strictly!)
• Incubation Days: ≥ 14 (or as per monograph)
• Cell Survival: ≥ 80%
• Virus Control Titer: Sufficient to confirm sensitivity
• Residual Formalin/BPL: Within safe limit
💡 Usage tips:
1. Asepsis: During safety testing, risk of contamination must be excluded to prevent false-positive results leading to rejection of a good batch.
2. Observation: CPE (Cytopathic Effect) must be assessed by a qualified microbiologist regularly.
3. Confirmation: If growth is suspected, a confirmatory test (e.g., PCR or immunofluorescence) is performed.
4. Process Validation: Inactivation process must be validated with a large safety margin (Kinetics of Inactivation).
5. Documentation: All cell observations must be documented by day.
⚠️ Note: Unlike live vaccines where we measure titer, here we prove the absence of titer. This is a qualitative test ("Pass/Fail"), although based on method sensitivity.input.csv
BatchNumber,ProductName,TotalSubcultures,PositiveSubcultures,IncubationDays,CellControlSurvival_Percent,VirusControlTiter_Log10,InactivatingAgent,ResidualInactivator_ppm INV-SAFE-2026-001,Inactivated Polio Vaccine,3,0,21,95.0,6.5,Formalin,15.0 INV-SAFE-2026-002,Rabies Vaccine,2,0,14,90.0,5.8,BPL,2.0 INV-FAIL-2026-003,Influenza Split,3,1,21,92.0,6.0,Formalin,18.0
URS & FS — User Requirements and Functional Specification
This document describes the controlled interface and behaviour of InactivatedVaccineSafetyTest_QualityChecker for Inactivated Vaccine Safety Test Quality Checker.
Domain limits and critical parameters
Key fragments from the source description are shown below. Before production use, limits must be verified against the approved specification, registration dossier and local SOPs.
- ℹ️ Utility assesses the completeness of pathogen inactivation in inactivated vaccines (IPV, Rabies, Influenza, Encephalitis) according to Ph. Eur. 2.6.16, 2.6.17 and WHO requirements:
- • System Validity: Cell control must be viable, and virus control (sensitivity) must show growth.
- ⚠️ CRITICAL:
- • Detection of even one positive subculture means INCOMPLETE INACTIVATION. This is a critical batch failure.
- • Sensitivity: Method must be able to detect 1 infectious dose.
- • Residual Inactivator: Its presence in small doses is sometimes required to guarantee that any accidental survivors are inactivated during storage, but its level is strictly toxicologically limited.
- • Specificity: Used cell lines must be susceptible to the given virus.
- • Compliance with GMP and Pharmacopoeia requirements
- Critical parameters:
- • Incubation Days: ≥ 14 (or as per monograph)
- • Cell Survival: ≥ 80%
- • Residual Formalin/BPL: Within safe limit
- 1. Asepsis: During safety testing, risk of contamination must be excluded to prevent false-positive results leading to rejection of a good batch.
- 2. Observation: CPE (Cytopathic Effect) must be assessed by a qualified microbiologist regularly.
- 3. Confirmation: If growth is suspected, a confirmatory test (e.g., PCR or immunofluorescence) is performed.
- 4. Process Validation: Inactivation process must be validated with a large safety margin (Kinetics of Inactivation).
- 5. Documentation: All cell observations must be documented by day.
URS — User Requirements Specification
| ID | Requirement | Criticality | Acceptance criterion |
|---|---|---|---|
| URS-001 | The utility shall accept an input.csv file for Inactivated Vaccine Safety Test Quality Checker with headers defined in the data contract. | High | The file is processed without manual header editing. |
| URS-002 | The utility shall perform deterministic QC evaluation without machine learning and without probabilistic conformance decisions. | High | Identical input data, rule version and configuration produce reproducible results. |
| URS-003 | The utility shall validate mandatory fields, data types, ranges, units and domain plausibility. | High | Schema, conversion and range errors are explicitly reported. |
| URS-004 | The utility shall apply domain limits and rules from the description, approved specification, registration dossier and local SOPs. | High | Each check has PASS/WARNING/FAIL and a clear message. |
| URS-005 | The utility shall generate output.json with machine-readable results, source values, warnings, failures and critical findings. | High | JSON is suitable for LIMS/ELN/MES integration and QA/QC review. |
| URS-006 | The utility shall preserve traceability between batch/sample, input file, applied rules and final status. | High | Output contains identifiers, checked parameters and audit metadata. |
| URS-007 | The documentation shall support IQ/OQ/PQ, CSV/CSA and review by internal QA or inspectors. | Medium | URS, FS, input/output contract and test scenarios are supplied with the utility. |
| URS-008 | The utility shall be used as a QC decision-support tool and not as a substitute for approved specifications and QA/QP release decision. | Medium | Documentation states change control and limit-verification expectations. |
input.csv contract
| # | Field | Type | Sample | Purpose |
|---|---|---|---|---|
| 1 | BatchNumber | string / controlled vocabulary | INV-SAFE-2026-001 | Batch or lot identifier used for traceability. |
| 2 | ProductName | string / controlled vocabulary | Inactivated Polio Vaccine | Product or dosage-form name under evaluation. |
| 3 | TotalSubcultures | decimal | 3 | Controlled input parameter for deterministic QC rules. |
| 4 | PositiveSubcultures | flag / boolean | 0 | Controlled input parameter for deterministic QC rules. |
| 5 | IncubationDays | integer / decimal | 21 | Time parameter for process, incubation, storage or analytical workflow. |
| 6 | CellControlSurvival_Percent | decimal | 95.0 | Control point/control sample for assay run validity. |
| 7 | VirusControlTiter_Log10 | string / controlled vocabulary | 6.5 | Control point/control sample for assay run validity. |
| 8 | InactivatingAgent | string / controlled vocabulary | Formalin | Controlled input parameter for deterministic QC rules. |
| 9 | ResidualInactivator_ppm | decimal | 15.0 | Impurity/residual component used for specification conformance assessment. |
BatchNumber,ProductName,TotalSubcultures,PositiveSubcultures,IncubationDays,CellControlSurvival_Percent,VirusControlTiter_Log10,InactivatingAgent,ResidualInactivator_ppm INV-SAFE-2026-001,Inactivated Polio Vaccine,3,0,21,95.0,6.5,Formalin,15.0 INV-SAFE-2026-002,Rabies Vaccine,2,0,14,90.0,5.8,BPL,2.0 INV-FAIL-2026-003,Influenza Split,3,1,21,92.0,6.0,Formalin,18.0
Input validation rules
| ID | Field | Rule | Criticality |
|---|---|---|---|
| VR-001 | BatchNumber | The field shall match an approved dictionary or accepted string representation. | High |
| VR-002 | ProductName | The field shall match an approved dictionary or accepted string representation. | High |
| VR-003 | TotalSubcultures | The field shall match an approved dictionary or accepted string representation. | High |
| VR-004 | PositiveSubcultures | The field shall match an approved dictionary or accepted string representation. | Medium |
| VR-005 | IncubationDays | The field shall match an approved dictionary or accepted string representation. | Medium |
| VR-006 | CellControlSurvival_Percent | The field shall match an approved dictionary or accepted string representation. | Medium |
| VR-007 | VirusControlTiter_Log10 | The field shall match an approved dictionary or accepted string representation. | Medium |
| VR-008 | InactivatingAgent | The field shall match an approved dictionary or accepted string representation. | Medium |
| VR-009 | ResidualInactivator_ppm | The field shall match an approved dictionary or accepted string representation. | Medium |
FS — Functional Specification
| ID | Function | Implementation |
|---|---|---|
| FS-001 | CLI execution | Support execution modes: demo mode without arguments and production mode input.csv output.json. |
| FS-002 | CSV import | Read input.csv in UTF-8/CSV-compatible format and validate header and expected columns. |
| FS-003 | Schema validation | Check mandatory fields, column count, unknown key fields and empty mandatory values. |
| FS-004 | Type conversion | Convert numeric, flag and text values; invalid format is recorded as a row-level error. |
| FS-005 | Domain rule engine | Apply rules for Inactivated Vaccine Safety Test Quality Checker, including critical limits from the description and approved specification. |
| FS-006 | Status aggregation | Produce final status: FAIL for critical failure, WARNING for non-critical deviation, PASS for conformance. |
| FS-007 | JSON export | Write output.json with detailed checks, source values, warnings, failures and critical findings. |
| FS-008 | Audit support | Keep result structure suitable for review, deviation investigation and calculation reproduction. |
| FS-009 | Integration contract | Support the scenario LIMS/ELN/MES → input.csv → utility → output.json → portal/admin review. |
| FS-010 | Error handling | Return explicit messages for missing file, empty CSV, invalid schema, output write failure and invalid format. |
Example output.json
{
"utilityId": "inactivatedvaccinesafetytest-qualitychecker",
"utilityFolder": "InactivatedVaccineSafetyTest_QualityChecker",
"package": "huvac",
"overallStatus": "PASS|WARNING|FAIL",
"sourceFile": "input.csv",
"processedAtUtc": "2026-06-10T00:00:00Z",
"checks": [
{
"parameter": "BatchNumber",
"value": "INV-SAFE-2026-001",
"status": "PASS|WARNING|FAIL",
"message": "Deterministic rule-based check result",
"ruleReference": "FS-RULE-001"
},
{
"parameter": "ProductName",
"value": "Inactivated Polio Vaccine",
"status": "PASS|WARNING|FAIL",
"message": "Deterministic rule-based check result",
"ruleReference": "FS-RULE-002"
},
{
"parameter": "TotalSubcultures",
"value": "3",
"status": "PASS|WARNING|FAIL",
"message": "Deterministic rule-based check result",
"ruleReference": "FS-RULE-003"
},
{
"parameter": "PositiveSubcultures",
"value": "0",
"status": "PASS|WARNING|FAIL",
"message": "Deterministic rule-based check result",
"ruleReference": "FS-RULE-004"
},
{
"parameter": "IncubationDays",
"value": "21",
"status": "PASS|WARNING|FAIL",
"message": "Deterministic rule-based check result",
"ruleReference": "FS-RULE-005"
},
{
"parameter": "CellControlSurvival_Percent",
"value": "95.0",
"status": "PASS|WARNING|FAIL",
"message": "Deterministic rule-based check result",
"ruleReference": "FS-RULE-006"
},
{
"parameter": "VirusControlTiter_Log10",
"value": "6.5",
"status": "PASS|WARNING|FAIL",
"message": "Deterministic rule-based check result",
"ruleReference": "FS-RULE-007"
},
{
"parameter": "InactivatingAgent",
"value": "Formalin",
"status": "PASS|WARNING|FAIL",
"message": "Deterministic rule-based check result",
"ruleReference": "FS-RULE-008"
},
{
"parameter": "ResidualInactivator_ppm",
"value": "15.0",
"status": "PASS|WARNING|FAIL",
"message": "Deterministic rule-based check result",
"ruleReference": "FS-RULE-009"
}
],
"criticalFindings": [],
"warnings": [],
"audit": {
"inputHash": "sha256:<calculated at runtime>",
"rulesVersion": "<utility executable version>",
"documentation": "InactivatedVaccineSafetyTest_QualityChecker.documentation.html"
}
}
Traceability matrix
| URS | FS | Test | Evidence |
|---|---|---|---|
| URS-001 | FS-001, FS-002 | OQ-001 | Verify execution and import of valid input.csv. |
| URS-002 | FS-005, FS-006 | OQ-004 | Repeat the same dataset and compare output.json. |
| URS-003 | FS-003, FS-004, FS-010 | OQ-002, OQ-003 | Verify missing columns and invalid types. |
| URS-004 | FS-005, FS-006 | OQ-004, PQ-001 | Verify critical deviations on real/boundary data. |
| URS-005 | FS-007, FS-009 | OQ-005 | Verify JSON schema and downstream-system suitability. |
| URS-006 | FS-008 | OQ-006 | Verify identifiers and audit metadata. |
| URS-007 | FS-008, FS-010 | IQ-001, OQ-007 | Verify documentation completeness and control evidence. |
| URS-008 | FS-005, FS-008 | PQ-002 | Verify review workflow and no replacement of QA decision. |
IQ/OQ/PQ test scenarios
| ID | Scenario | Expected result |
|---|---|---|
| IQ-001 | Verify executable, input.csv, documentation and checksum availability. | Delivery set is complete; version is recorded. |
| OQ-001 | Valid sample row from input.csv. | PASS or acceptable WARNING according to rules. |
| OQ-002 | Remove a mandatory CSV column. | Schema error or FAIL with missing-column reference. |
| OQ-003 | Place a non-numeric value into a numeric field. | Type-conversion error with row/field reference. |
| OQ-004 | Set a critical parameter outside the limit. | FAIL and critical finding. |
| OQ-005 | Verify output.json structure. | All mandatory sections are present and JSON is valid. |
| OQ-006 | Verify batch/sample traceability. | Input and result identifiers match. |
| PQ-001 | Verify 3–5 real user batches/samples. | Result is confirmed by QC/QA review. |
| PQ-002 | Verify deviation workflow and manual QA decision. | Utility supports review but does not replace approved decision. |
QA/QC and change control
- Do not rename columns without updating validator, documentation and test set.
- Retain
input.csv,output.json, executable version and checksum. - Before production use, perform IQ/OQ/PQ or equivalent CSV/CSA verification.
- Critical limits shall be verified against the approved specification, registration dossier and local SOPs.
- The utility provides structured QC decision support; final release decision remains with QA/QP and approved procedures.
Included in packages
Biopharmaceuticals Extended QC Suite
Extended QC utility coverage for mAbs, biosimilars, proteins, insulins, vaccines, mRNA/LNP, HCP, sterile release, microbiology, water, cleanroom and stability workflows.
OpenHuvac — Human Vaccine QC Utilities
Huvac contains QC utilities for human vaccines: adjuvants, antigen potency, sterility, endotoxins, cold chain, mRNA controls, container closure and stability checks.
OpenInfectious Diseases QC Suite
QC utility package for infectious diseases: antibacterial, antiviral, antifungal and antiparasitic products, microbiology, sterility, endotoxins, viral safety and vaccine release checks.
Open